"Up to an additional $20 million may, at Pharmaxis’ option, be invested by NovaQuest from January 30, 2014, SUBJECT TO PHARMAXIS MEETING CERTAIN COMMERCIAL AND REGULATORY PERFORMANCE CRITERIA"...
Part of this criteria is the commencing of the US CF trial, what are the other parts of this criteria?
- Forums
- ASX - By Stock
- SNT
- cash 2x market cap
cash 2x market cap, page-24
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.92M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 4.0¢ | $4K | 100K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 360214 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 99980 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 360214 | 0.039 |
3 | 1218558 | 0.038 |
2 | 550000 | 0.037 |
6 | 687200 | 0.036 |
5 | 985528 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 99980 | 1 |
0.042 | 100000 | 1 |
0.043 | 200000 | 1 |
0.045 | 200000 | 1 |
0.046 | 69660 | 2 |
Last trade - 10.42am 15/11/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online